Health
China’s Clover says its COVID-19 vaccine candidate shows immune response in mice – Reuters
Chinese biotechnology company Clover Biopharmaceuticals said on Tuesday the modified version of its COVID-19 vaccine candidate showed a strong immune response against…
Chinese biotechnology company Clover Biopharmaceuticals said on Tuesday the modified version of its COVID-19 vaccine candidate showed a strong immune response against the original strain of the virus and some variants during animal testing.
Clover said in a statement its vaccine candidate demonstrated a “neutralisation” against the South African, Brazilian and UK variants among mice.
The company is testing a COVID-19 vaccine candidate containing an adjuvant, typically designed to boost the efficacy…
-
Noosa News14 hours agoMan dies in Brisbane crash, women and girl rushed to hospital
-
General23 hours agoProductivity summit ends day two with progress on rules changes to boost housing supply
-
Noosa News20 hours agoChilling new details emerge in terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
Business19 hours agoAre BHP shares are buy after its results?